# EDGAR Filing Document

**Accession Number:** 0000711404
**File Stem:** 0001908671-26-000001
**Filing Date:** 2026-1
**Character Count:** 8252
**Document Hash:** d04f6917e79c17de48adf7ebadfc63ab
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001908671-26-000001.hdr.sgml**: 20260112

**ACCESSION NUMBER**: 0001908671-26-000001

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260108

**FILED AS OF DATE**: 20260112

**DATE AS OF CHANGE**: 20260112

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Warner Gerard H III
- **CENTRAL INDEX KEY:** 0001908671

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-08597
- **FILM NUMBER:** 26526984

**MAIL ADDRESS:**
- **STREET 1:** C/O COOPER COMPANIES INC.
- **STREET 2:** 6101 BOLLINGER CANYON ROAD, SUITE 500
- **CITY:** SAN RAMON
- **STATE:** CA
- **ZIP:** 94583
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** COOPER COMPANIES, INC.
- **CENTRAL INDEX KEY:** 0000711404
- **STANDARD INDUSTRIAL CLASSIFICATION:** OPHTHALMIC GOODS [3851]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 942657368
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**BUSINESS ADDRESS:**
- **STREET 1:** 6101 BOLLINGER CANYON ROAD
- **STREET 2:** SUITE 500
- **CITY:** SAN RAMON
- **STATE:** CA
- **ZIP:** 94583
- **BUSINESS PHONE:** 9254603600

**MAIL ADDRESS:**
- **STREET 1:** 6101 BOLLINGER CANYON ROAD
- **STREET 2:** SUITE 500
- **CITY:** SAN RAMON
- **STATE:** CA
- **ZIP:** 94583

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** COOPER COMPANIES INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** COOPERVISION INC
- **DATE OF NAME CHANGE:** 19870701

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Warner Gerard H III<br><sub>(Last) (First) (Middle)</sub><br>C/O THE COOPER COMPANIES, INC.<br>6101 BOLLINGER CANYON ROAD, SUITE 500<br><sub>(Street)</sub><br>SAN RAMON, CA 94583<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-01-08 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President, CooperVision, Inc._ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COOPER COMPANIES, INC. [ COO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-01-08 |  | M |  | 2652.00 | A | $0.00 | 20971.00 | D |  |
| Common Stock | 2026-01-08 |  | M |  | 3154.00 | A | $0.00 | 24125.00 | D |  |
| Common Stock | 2026-01-08 |  | M |  | 1232.00 | A | $0.00 | 25357.00 | D |  |
| Common Stock | 2026-01-08 |  | M |  | 2940.00 | A | $0.00 | 28297.00 | D |  |
| Common Stock | 2026-01-08 |  | M |  | 1540.00 | A | $0.00 | 29837.00 | D |  |
| Common Stock | 2026-01-08 |  | F |  | 1714.00 | D | $83.13 | 28123.00 | D |  |
| Common Stock | 2026-01-08 |  | F |  | 629.00 | D | $83.13 | 27494.00 | D |  |
| Common Stock | 2026-01-08 |  | F |  | 787.00 | D | $83.13 | 26707.00 | D |  |
| Common Stock | 2026-01-08 |  | F |  | 1501.00 | D | $83.13 | 25206.00 | D |  |
| Common Stock | 2026-01-08 |  | F |  | 1354.00 | D | $83.13 | 23852.00 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | $0.00 | 2026-01-08 |  | M |  |  | 1232.00 | <sup>(1)</sup> | <sup>(2)</sup> | Common Stock | 1232.00 | $0.00 | 0.00 | D |  |
| Restricted Stock Units | $0.00 | 2026-01-08 |  | M |  |  | 1540.00 | <sup>(3)</sup> | <sup>(2)</sup> | Common Stock | 1540.00 | $0.00 | 0.00 | D |  |
| Restricted Stock Units | $0.00 | 2026-01-08 |  | M |  |  | 2652.00 | <sup>(4)</sup> | <sup>(2)</sup> | Common Stock | 2652.00 | $0.00 | 2652.00 | D |  |
| Restricted Stock Units | $0.00 | 2026-01-08 |  | M |  |  | 2940.00 | <sup>(5)</sup> | <sup>(2)</sup> | Common Stock | 2940.00 | $0.00 | 5876.00 | D |  |
| Restricted Stock Units | $0.00 | 2026-01-08 |  | M |  |  | 3154.00 | <sup>(6)</sup> | <sup>(2)</sup> | Common Stock | 3154.00 | $0.00 | 9462.00 | D |  |

---

### Footnotes:

(1) This award vests 50% in year 3 and 50% in year 4 - 1,232 shares on 1/8/2025, 1,232 shares on 1/8/2026.

(2) This award has no expiration date. Restricted Stock Units will either vest or be forfeited.

(3) This award vests 25%/year over 4 years - 1,540 shares on 1/8/2023, 1,540 shares on 1/8/2024, 1,536 shares on 1/8/2025, 1,540 shares on 1/8/2026.

(4) This award vests 25%/year over 4 years - 2,652 shares on 1/8/2024, 2,656 shares on 1/8/2025, 2,652 shares on 1/8/2026, 2,652 shares on 1/8/2027 - subject to continued service.

(5) This award vests 25%/year over 4 years - 2,940 shares on 1/8/2025, 2,940 shares on 1/8/2026, 2,936 shares on 1/8/2027, 2,940 shares on 1/8/2028 - subject to continued service.

(6) This award vests 25%/year over 4 years - 3,154 shares on 1/8/2026, 3,154 shares on 1/8/2027, 3,154 shares on 1/8/2028, 3,154 shares on 1/8/2029 - subject to continued service.

**Signature:** /s/ Gerard H Warner III by Greta Kolcon, as Attorney-in-Fact  
**Date:** 2026-01-12

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**